Metals & critical materials

Palladium & Platinum-Group Metals

Selected palladium and platinum-group-metal transaction assessment with enhanced assay, custody, origin and sanctions controls.

Market coverage

Product-specific qualification. Transaction-specific execution.

Palladium and other PGMs require exact product-form, purity, assay, refinery, custody and end-use evidence. Bethar evaluates only identifiable physical pathways with qualified counterparties and enhanced compliance review.

01

Indicative product forms

  • Refined palladium and selected PGMs
  • Industrial sponge or powder
  • Qualified intermediate materials
  • Traceable recycling feedstocks
02

Origin pathways

Identified mine, refiner, processor or lawful title-holder pathways with auditable custody evidence.

03

Destination markets

Approved automotive, chemical, electronics, jewellery and specialist industrial users or processors.

Physical execution

From specification to delivery.

01

Purity, assay and acceptance protocol

02

Reference pricing and premium methodology

03

Secure transport, storage and insurance

04

Title, payment and performance controls

Compliance perimeter

Evidence before commitment.

01

Sanctions and origin screening

02

Refiner and beneficial-owner diligence

03

Responsible-minerals and custody evidence

04

End-user, end-use and fraud controls

Disclosure boundary

Coverage is not an offer.

References to palladium & platinum-group metals describe an area in which Bethar may originate, structure or develop a qualifying physical transaction. They do not state that Bethar holds inventory, controls production, maintains a binding offer or is authorised for every product, origin, destination or jurisdiction.

Any transaction remains subject to product specification, counterparty approval, compliance clearance, logistics feasibility, bankability, economics and definitive contract.

Legal, compliance & data

Business enquiries

Bring us a defined requirement.

Product, specification, volume, origin or destination, delivery window, Incoterm and proposed payment instrument. We will confirm whether the mandate is within scope.